Sentences with phrase «international rare diseases research»

The progress on the previous goals has shown that the international rare diseases research community is eager to share knowledge and experience, and work collaboratively across borders in order to bring diagnoses and therapies to patients.

Selected platforms, tools, standards, and guidelines must be of fundamental importance to the international rare diseases research and development community.

In line with the objectives of the International Rare Disease Research Consortium (IRDiRC), we aim to develop novel tools that will allow to make more accurate diagnoses, predict the disease course and the efficacy of available treatments, and help developing new and better therapies for rare kidney diseases.

The International Rare Disease Research Consortium (IRDiRC) has created the label Recognized Resource (formerly known as IRDiRC Recommended) to highlight resources of fundamental importance to the international rare diseases research and development community.

The centers also plan to join the International Rare Disease Research Consortium, whose goal is to develop diagnoses of most rare diseases and treatments for about 200 disorders by 2020.

Not exact matches

The proportion of a rare type of stroke, called spontaneous subarachnoid hemorrhage or sSAH, is increasing among pregnant women, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.

Investigating mouse models for biological for research The congress aims to promote the International Mouse Phenotyping Consortium (IMPC) mouse lines, importance of mouse phenotyping & clinical and drug discovery collaboration, to present progresses performed by IMPC with regards CRISPR editing genome, rare diseases, microbiota and ageing pipeline, as well as illustration of examples of scientific projects about «Animal models for human diseases» and recent developments in mouse models phenotyping imaging.

Over the last two decades, important contributions were made at national, European and international levels to foster collaboration into rare diseases research.

Additionally, IRDiRC also published articles on its Policies and Guidelines, A Global Approach to Rare Diseases Research and Orphan Products Development, International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases, and the position statement of the Patient - Centered Outcome Measures Task Force, while contributed to some others, as on the importance of international collaboration for rare diseases reseaRare Diseases Research and Orphan Products Development, International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases, and the position statement of the Patient - Centered Outcome Measures Task Force, while contributed to some others, as on the importance of international collaboration for rare diseases rResearch and Orphan Products Development, International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases, and the position statement of the Patient - Centered Outcome Measures Task Force, while contributed to some others, as on the importance of international collaboration for rare diseaInternational Cooperation to Enable the Diagnosis of All Rare Genetic Diseases, and the position statement of the Patient - Centered Outcome Measures Task Force, while contributed to some others, as on the importance of international collaboration for rare diseases reseaRare Genetic Diseases, and the position statement of the Patient - Centered Outcome Measures Task Force, while contributed to some others, as on the importance of international collaboration for rare diseainternational collaboration for rare diseases researare diseases researchresearch.

The RE (ACT) Congress — International Congress on Research of Rare and Orphan Diseases was initiated in 2012 by the BLACKSWAN Foundation to create a human platform to scale up scientific cooperation on rare and orphan diseRare and Orphan Diseases was initiated in 2012 by the BLACKSWAN Foundation to create a human platform to scale up scientific cooperation on rare and orphan diserare and orphan disease.

About the International Rare Diseases Research Consortium (IRDiRC): IRDiRC was formed to unite public and private sector funders of research, patient advocacy groups, and scientific researchers to advance rare diseases research worldwRare Diseases Research Consortium (IRDiRC): IRDiRC was formed to unite public and private sector funders of research, patient advocacy groups, and scientific researchers to advance rare diseases research woResearch Consortium (IRDiRC): IRDiRC was formed to unite public and private sector funders of research, patient advocacy groups, and scientific researchers to advance rare diseases research woresearch, patient advocacy groups, and scientific researchers to advance rare diseases research worldwrare diseases research woresearch worldwide.

Funded as part of the EU's commitment to the International Rare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare diseaRare Diseases Research Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare dResearch Consortium (IRDiRC), RD - Connect is a global infrastructure project that links omics data with databases, registries, biobanks, and clinical bioinformatics tools into a central research resource for rare dresearch resource for rare disearare diseases.

Capitalizing on the momentum of progress made in rare diseases research over the past six years, the International Rare Diseases Research Consortium (IRDiRC) devised a new set of global rare disease goals for the upcoming decrare diseases research over the past six years, the International Rare Diseases Research Consortium (IRDiRC) devised a new set of global rare disease goals for the upcomingresearch over the past six years, the International Rare Diseases Research Consortium (IRDiRC) devised a new set of global rare disease goals for the upcoming decRare Diseases Research Consortium (IRDiRC) devised a new set of global rare disease goals for the upcomingResearch Consortium (IRDiRC) devised a new set of global rare disease goals for the upcoming decrare disease goals for the upcoming decade.